Download PDF
Ultraschall Med 2013; 34(5): 483-484
DOI: 10.1055/s-0033-1346750
EFSUMB
Georg Thieme Verlag KG Stuttgart · New York

Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe - between guidelines and reality

Further Information

Publication History

Publication Date:
18 October 2013 (online)

Also available at
    Permissions and Reprints

Hepatocellular carcinoma is the sixth most common cancer, and the third cause of cancer related death worldwide [1]. The pattern of HCC occurrence has a clear geographical distribution, with the highest incidence rates in several regions from East Asia and sub-Saharan Africa.

 

  • References

  • 1 EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56 (4) 908-943
    Google Scholar
  • 2 GLOBOCAN 2002 Cancer statistics. http://www-dep.iarc.fr/ accessed September 4th 2013
    PubMedGoogle Scholar
  • 3 Mazzaferro V, Llovet JM, Miceli R et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10 (1) 35-43
    CrossrefPubMedGoogle Scholar
  • 4 Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003; 39: 1076-1084
    CrossrefPubMedGoogle Scholar
  • 5 Kim CK, Lim JH, Lee WJ. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med 2001; 20: 99-104
    CrossrefPubMedGoogle Scholar
  • 6 Sato T, Tateishi R, Yoshida H, Ohki T, Masuzaki R, Imamura J et al. Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C. Hepatol Int 2009; 3: 544-550
    CrossrefPubMedGoogle Scholar
  • 7 Varela M, Reig M, de la Mata M. Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers. Med Clin (Barc) 2010; 134 (13) 569-576
    CrossrefPubMedGoogle Scholar
  • 8 Stroffolini T, Trevisani F, Pinzello G. Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance. Dig Liver Dis 2011; 43 (11) 875-880
    PubMedGoogle Scholar
  • 9 Romanian Society of Gastroenterology and Hepatology. http://www.srgh.ro/pagina.php?idS=3&idPS=3 accesed September 5th 2013
    PubMed
  • 10 Kuske L, Mensen A, Müllhaupt B et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss Med Wkly 2012; 142: w13651
    PubMedGoogle Scholar
  • 11 Kennedy NA, Rodgers A, Altus R, McCormick R, Wundke R, Wigg AJ. Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study. Intern Med J 2013; 43 (7) 772-777
    CrossrefPubMedGoogle Scholar
  • 12 Rosa I, Denis J, Renard P et al. A French multicentric longitudinal descriptive study of hepatocellular carcinoma management (the CHANGH cohort): preliminary results. J Hepatol 2010; 53: S231-S232
    PubMedGoogle Scholar
  • 13 Borzio M, Fornari F, De Sio I et al. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. Future Oncol 2013; 9 (2) 283-94
    CrossrefPubMedGoogle Scholar